References
- Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci. 2020;27(1):104. doi:10.1186/s12929-020-00695-2.
- Garg RK, and Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2022;43(1):3–40.
- Eleiwa TK, Gaier ED, Haseeb A, ElSheikh RH, Sallam AB, Elhusseiny AM. Adverse ocular events following COVID-19 vaccination. Inflamm Res. 2021;70(10–12):1005–1009. doi:10.1007/s00011-021-01506-6.
- Cheng JY, Margo CE. Ocular adverse events following vaccination: overview and update. Surv Ophthalmol. Published online April 16, 2021;67:S0039-6257(21)00099–0. doi:10.1016/j.survophthal.2021.04.001.
- Stübgen JP. A literature review on optic neuritis following vaccination against virus infections. Autoimmun Rev. 2013;12(10):990–997. doi:10.1016/j.autrev.2013.03.012.
- Moradian S, Ahmadieh H. Early onset optic neuritis following measles-rubella vaccination. J Ophthalmic Vis Res. 2008;3:118–122.
- Poser CM. Neurological complications of swine influenza vaccination. Acta Neurol Scand. 1982;66:413–431. doi:10.1111/j.1600-0404.1982.tb06864.x.
- Jun B, Fraunfelder FW. Atypical optic neuritis after inactivated influenza vaccination. Neuro-Ophthalmology. 2018;42(2):105–108. doi:10.1080/01658107.2017.1335333.
- Vera-Lastra O, Medina G, Cruz-Dominguez MP, Jara LJ, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol. 2013;9:361–373. doi:10.1586/eci.13.2.
- Agmon-Levin N, Kivity S, Szyper-Kravitz M, Shoenfeld Y. Transverse myelitis and vaccines: a multi-analysis. Lupus. 2009;18:1198–1204. doi:10.1177/0961203309345730.
- Algahtani H, Shirah B, Ibrahim B, Malik YA, Makkawi S. Clinical and radiological characteristics of neuromyelitis optica spectrum disorder: the experience from Saudi Arabia. Mult Scler Relat Disord. 2021;47:102668. doi:10.1016/j.msard.2020.102668.
- Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler. 2012;18:5–10. doi:10.1177/1352458511431077.
- Cai H, Zhou R, Jiang F, Zeng Q, Yang H. Vaccination in neuromyelitis optica spectrum disorders: friend or enemy? Multiple sclerosis and related disorders. Multiple Sclerosis Rela Disord. Published online November, 2021;58:103394. doi:10.1016/j.msard.2021.103394.
- Vadalà M, Poddighe D, Laurino C, Palmieri B. Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? EPMA J. 2017;8(3):295–311. doi:10.1007/s13167-017-0101-y.
- Badrawi N, Kumar N, Albastaki U. Post COVID-19 vaccination neuromyelitis optica spectrum disorder: case report & MRI findings. Radiol Case Rep. 2021;16(12):3864–3867. doi:10.1016/j.radcr.2021.09.033.
- Chen S, Fan XR, He S, Zhang JW, Li SJ. Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurol Sci. 2021;42(9):3537–3539. doi:10.1007/s10072-021-05427-4.
- Caliskan I, Bulus E, Afsar N, Altintas A. A case with new-onset neuromyelitis optica spectrum disorder following covid-19 mRNA BNT162b2 vaccination. Neurologist. Published online February 21, 2022;27:147–150. doi:10.1097/NRL.0000000000000420.